Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
First Light Asset Management, LLC TELA TELA Bio, Inc. 13G 11.12% 2y
PRICE T ROWE ASSOCIATES INC /MD/ GLUE Monte Rosa Therapeutics, Inc. 13G/A 9.9% 2y
PUBLIC INVESTMENT FUND EA Electronic Arts Inc. 13G/A 9.2% 2y
Oaktree Capital Holdings, LLC STHO Star Holdings 13G/A 7.5% 2y
Sculptor Capital LP XFIN ExcelFin Acquisition Corp Class A Common Stock 13G/A 0% 2y
SILVERCREST ASSET MANAGEMENT GROUP LLC PLYM Plymouth Industrial REIT, Inc. 13G/A 5.5% 2y
Brave Warrior Advisors, LLC PRI Primerica, Inc. 13G/A 6.03% 2y
Changlin Liang DDL Dingdong (Cayman) Ltd 13G/A 26% 2y
T. Rowe Price Investment Management, Inc. TRNO Terreno Realty Corp 13G 5.1% 2y
HARRIS ASSOCIATES L P CBRE Cbre Group, Inc. 13G 5.25% 2y
FPR PARTNERS LLC ALIT Alight, Inc. / Delaware 13G/A 5.6% 2y
BAKER BROS. ADVISORS LP ZYME Zymeworks Inc. 13G/A 0.04% 2y
NOMURA HOLDINGS INC LHC Leo Holdings Corp. II 13G/A 0% 2y
MANGROVE PARTNERS IM, LLC MREO Mereo BioPharma Group plc 13G 6.24% 2y
PRICE T ROWE ASSOCIATES INC /MD/ EQT EQT Corp 13G 12.9% 2y
GATE CITY CAPITAL MANAGEMENT, LLC ALCO Alico, Inc. 13G 9.3% 2y
ALLIANCEBERNSTEIN L.P. GLDD Great Lakes Dredge & Dock CORP 13G/A 6.9% 2y
Ramaswamy Vivek ROIV Roivant Sciences Ltd. 13G/A 9.75% 2y
PRICE T ROWE ASSOCIATES INC /MD/ SDRL SEADRILL Ltd 13G 5.2% 2y
Gates Capital Management, Inc. CCSI Consensus Cloud Solutions, Inc. 13G/A 8.1% 2y
Lincoln Park Capital Fund, LLC WINT Windtree Therapeutics Inc 13G/A 6.18% 2y
Justin Rosenstein ASAN Asana, Inc. 13G/A 13.6% 2y
SRB CORP SAFT Safety Insurance Group Inc 13G/A 12.45% 2y
ARMISTICE CAPITAL, LLC BDRX Biodexa Pharmaceuticals Plc 13G/A 0.94% 2y
ARMISTICE CAPITAL, LLC MGNX Macrogenics Inc 13G/A 7.37% 2y
T. Rowe Price Investment Management, Inc. CCB Coastal Financial Corp 13G 6.4% 2y
Lynx1 Capital Management LP KNTE Kinnate Biopharma Inc. Common Stock 13G/A 4.2% 2y
8 KNOTS MANAGEMENT, LLC PNTG Pennant Group, Inc. 13G 6.14% 2y
PERCEPTIVE ADVISORS LLC FBRX Forte Biosciences, Inc. 13G/A 9.9% 2y
AMERIPRISE FINANCIAL INC RDUS Radius Recycling, Inc. Class A Common Stock 13G 5.93% 2y
METEORA CAPITAL, LLC KYCH Keyarch Acquisition Corporation Ordinary Shares 13G/A 5.92% 2y
BIOTECHNOLOGY VALUE FUND L P ITOS iTeos Therapeutics, Inc. Common Stock 13G/A 3.5% 2y
BlackRock Inc. SOUN Soundhound Ai, Inc. 13G 5.6% 2y
AMERIPRISE FINANCIAL INC EDR Endeavor Group Holdings, Inc. 13G 5.23% 2y
Hillhouse Investment Management, Ltd. SGMT Sagimet Biosciences Inc. 13G 6.8% 2y
Condire Management, LP GATO Gatos Silver, Inc. 13G 8.3% 2y
Robert Nelsen BEAM Beam Therapeutics Inc. 13G/A 6.8% 2y
Capital V LLC DSP Viant Technology Inc. 13G 64.7% 2y
Deep Track Capital, LP DYN Dyne Therapeutics, Inc. 13G/A 3.26% 2y
RA CAPITAL MANAGEMENT, L.P. URGN UroGen Pharma Ltd. 13G/A 9.99% 2y
BAKER BROS. ADVISORS LP MRTX Mirati Therapeutics, Inc. Common Stock 13G 0% 2y
MAIRS & POWER INC TNC Tennant Co 13G/A 6.57% 2y
Avoro Capital Advisors LLC ASND Ascendis Pharma A/S 13G/A 6.5% 2y
First Trust Capital Management L.P. KCGI Kensington Capital Acquisition Corp. V 13G 9.86% 2y
Blue Owl Capital Holdings LP SYRS Syros Pharmaceuticals, Inc. Common Stock 13G 5.74% 2y
Lynrock Lake LP TDC Teradata Corp 13G/A 5.2% 2y
Russell C. Horowitz MCHX Marchex Inc 13G 13.5% 2y
PERCEPTIVE ADVISORS LLC NVNO enVVeno Medical Corp 13G/A 9.9% 2y
ALLIANCEBERNSTEIN L.P. HMNF HMN Financial Inc 13G/A 9.8% 2y
AMERIPRISE FINANCIAL INC EDUC Educational Development Corp 13G/A 6.36% 2y